Latest Tax Considerations News

Insurance Australia Group Limited announces a quarterly ordinary dividend of AUD 1.443 per Capital Note 3, payable mid-December 2025, with a partly franked distribution rate of 5.79% per annum.

CSL Limited has updated its dividend announcement for the first half of FY2025, confirming a USD 1.62 per share ordinary dividend and clarifying currency payment arrangements for global shareholders.

Charter Hall Long WALE REIT has announced its latest quarterly distribution of AUD 0.06375 per security, accompanied by a Dividend Reinvestment Plan offering a 1% discount on new units. Key dates for investors include the ex-date on 29 September and payment on 14 November 2025.

Leo Lithium announces it will return remaining funds from the Goulamina sale to shareholders and delist from the ASX on 22 September 2025, following a strategic review and lack of suitable acquisitions.

Computershare Limited has announced an ordinary dividend of AUD 0.48 per share for the half-year ending June 2025, alongside a confirmed Dividend Reinvestment Plan price of AUD 37.64.

Mantle Minerals has announced a proposed capital return of $0.001 per share, subject to shareholder approval at its upcoming AGM, potentially distributing over $6 million back to investors.

BlackRock is reshaping its iShares Future Tech Innovators ETF by narrowing its focus to the 30 largest Nasdaq 100 companies and cutting management fees nearly in half, effective October 15, 2025.

Humm Group Limited has announced a fully franked ordinary dividend of AUD 0.0075 per share for the six months ending June 2025, alongside a Dividend Reinvestment Plan offering.

Ramsay Health Care has confirmed the payment of a fully franked ordinary dividend on its perpetual preference securities, clearing prior approval conditions and setting a payment date for October 2025.

Wesfarmers has announced a $1.50 per share capital management initiative, combining a $1.10 return of capital with a $0.40 fully-franked special dividend, pending shareholder approval at the upcoming AGM.

Austco Healthcare has reported a robust FY25 with revenues climbing 40% to $81.4 million and EBITDA jumping 62% to $13 million, driven by organic growth and strategic acquisitions.

Austco Healthcare Limited reported a record $81.4 million in revenue for FY25, driven by organic growth and acquisitions including G&S Technologies. EBITDA jumped 62% to $13 million, reflecting strong operational leverage.